Stock AND ANDLAUER HEALTHCARE GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Andlauer Healthcare Group Inc.

Equities

AND

CA0342231077

Healthcare Facilities & Services

Market Closed - Toronto S.E.
Other stock markets
 16:00:00 2024-05-03 EDT 		5-day change 1st Jan Change
41.05 CAD -1.96% Intraday chart for Andlauer Healthcare Group Inc. -1.18% +0.17%
05-03 Transcript : Andlauer Healthcare Group Inc., Q1 2024 Earnings Call, May 03, 2024
05-03 Andlauer Healthcare Group's Rating, Price Target Maintained at National Bank Following Q1 Results MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 753.9 1,539 2,244 1,982 1,703 1,696 - -
Enterprise Value (EV) 1 852.4 1,639 2,406 2,079 1,771 1,686 1,591 1,511
P/E ratio - - - - - - - -
Yield - 0.51% 0.37% 0.55% 0.83% 0.96% 1.22% 1.41%
Capitalization / Revenue 2.6 x 4.9 x 5.1 x 3.06 x 2.63 x 2.53 x 2.4 x 2.3 x
EV / Revenue 2.94 x 5.21 x 5.47 x 3.21 x 2.73 x 2.51 x 2.25 x 2.05 x
EV / EBITDA 12.1 x 20.8 x 20.2 x 11.9 x 10.8 x 10 x 8.65 x 7.91 x
EV / FCF 15.5 x 35.6 x 31.6 x 18.7 x 21.9 x 17.9 x 16 x 11.2 x
FCF Yield 6.46% 2.81% 3.16% 5.36% 4.57% 5.58% 6.24% 8.93%
Price to Book 12.3 x 17.2 x 6.39 x 4.5 x 3.62 x 3.26 x 2.94 x 2.66 x
Nbr of stocks (in thousands) 37,600 37,600 41,529 41,857 41,552 41,324 - -
Reference price 2 20.05 40.94 54.03 47.35 40.98 41.05 41.05 41.05
Announcement Date 20-03-12 21-02-24 22-03-02 23-03-02 24-03-05 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 290 314.3 440.1 648.4 648 670.7 708.3 737
EBITDA 1 70.55 78.91 119.3 174.5 163.8 168 184 191
EBIT 1 44.99 50.94 73.7 110.3 96.05 97.61 111.8 112
Operating Margin 15.52% 16.21% 16.75% 17.02% 14.82% 14.55% 15.79% 15.2%
Earnings before Tax (EBT) 42.35 - - - - - - -
Net income 29.77 - - - - - - -
Net margin 10.27% - - - - - - -
EPS - - - - - - - -
Free Cash Flow 1 55.07 46.04 76.06 111.4 80.9 94.04 99.3 135
FCF margin 18.99% 14.65% 17.28% 17.18% 12.48% 14.02% 14.02% 18.32%
FCF Conversion (EBITDA) 78.05% 58.34% 63.78% 63.84% 49.39% 55.98% 53.96% 70.68%
FCF Conversion (Net income) 184.95% - - - - - - -
Dividend per Share 2 - 0.2100 0.2000 0.2600 0.3400 0.3950 0.5000 0.5800
Announcement Date 20-03-12 21-02-24 22-03-02 23-03-02 24-03-05 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 133 148.4 169.4 164.9 165.8 164.8 157.4 156.8 169.1 161.1 167.6 167.5 174.7 180.9 175.6
EBITDA 1 35.77 39.39 46.33 44.07 44.68 40.47 39.54 39.01 44.77 148 41.96 42.21 44.22 45.46 45.55
EBIT 1 21.45 24.16 30.16 27.86 28.17 23.69 22.6 21.72 28.04 21.24 25.07 25.39 26.92 30.19 29.61
Operating Margin 16.13% 16.29% 17.8% 16.9% 16.99% 14.38% 14.36% 13.86% 16.59% 13.18% 14.96% 15.16% 15.41% 16.68% 16.87%
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income - - - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - - -
Dividend per Share 2 0.0500 0.0600 0.0600 0.0700 0.0700 0.0800 0.0800 0.0900 0.0900 - 0.1000 0.1100 0.1100 - -
Announcement Date 22-03-02 22-05-04 22-08-09 22-11-08 23-03-02 23-05-03 23-08-01 23-11-02 24-03-05 24-05-02 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 98.5 99.5 162 97.4 68.2 - - -
Net Cash position 1 - - - - - 10 105 185
Leverage (Debt/EBITDA) 1.396 x 1.26 x 1.361 x 0.5584 x 0.4161 x - - -
Free Cash Flow 1 55.1 46 76.1 111 80.9 94 99.3 135
ROE (net income / shareholders' equity) 26.4% 49.4% 26.2% 19.2% 14.5% 13.8% 15% -
ROA (Net income/ Total Assets) 12.2% - - - - - - -
Assets 244.8 - - - - - - -
Book Value Per Share 2 1.640 2.370 8.450 10.50 11.30 12.60 13.90 15.40
Cash Flow per Share 2 - 1.330 2.100 3.210 2.450 2.950 3.020 -
Capex 1 5.94 4.97 8.03 25.7 23.5 24.5 23.8 22
Capex / Sales 2.05% 1.58% 1.82% 3.97% 3.63% 3.65% 3.35% 2.99%
Announcement Date 20-03-12 21-02-24 22-03-02 23-03-02 24-03-05 - - -
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Andlauer Healthcare Group Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
41.05 CAD
Average target price
50 CAD
Spread / Average Target
+21.80%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ANDLAUER HEALTHCARE GROUP INC. Stock Andlauer Healthcare Group Inc.
+0.17% 1.24B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.70% 80.61B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.20% 70.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.86% 29.08B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.43% 16.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.43% 16.96B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.31% 15.26B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+3.42% 12.41B
PURE HEALTH HOLDING Stock Pure Health Holding
-30.70% 11.95B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
-6.75% 11.93B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. AND Stock
  4. Financials Andlauer Healthcare Group Inc.